Sender: |
|
Date: |
Fri, 16 Nov 2012 14:54:07 -0500 |
MIME-version: |
1.0 |
Reply-To: |
|
Content-type: |
multipart/alternative;
boundary=------------070201040801020703090302 |
Subject: |
|
From: |
|
In-Reply-To: |
|
Comments: |
|
Parts/Attachments: |
|
|
CORRECTION: The defense date is Thursday, November 29
>
>> Dissertation Defense Announcement
>> To: The George Mason University Community
>>
>> *Candidate: Todd W. Hawley
>> Program: PhD Biosciences*
>>
>> *Date: Thursday November 29, 2012
>> Time: 11:00 a.m.
>> Place: George Mason University
>> Krasnow Institute Conference Room
>> Fairfax Campus
>> <http://www.gmu.edu/resources/welcome/Directions-to-GMU.html>*
>>
>> Committee Chair: Dr. Yuntao Wu
>> Committee members: Dr. Ancha Baranova, Dr. Geraldine Grant, Dr.
>> Harold Morowitz
>>
>> *Title: "Discovery and Mechanism of Action of Cyclonucleoside
>> Anti-HIV Activity"*
>>
>> The dissertation is on reserve in the Johnson Center Library, Fairfax
>> campus.
>> The doctoral project will not be read at the meeting, but should be
>> read in advance.
>>
>> All members of the George Mason University community are invited to
>> attend.
>>
>>
>> *ABSTRACT:*
>> Over 30 million people worldwide are currently infected with HIV, and
>> even after nearly 30 years of research, an effective cure or vaccine
>> has yet to be found. Given this fact, it is a high priority to
>> discover and develop novel small molecule anti-retrovirals that
>> preferably target cellular proteins or a new step in the HIV life
>> cycle. With this in mind, a novel anti-HIV drug screen utilizing
>> live virus was developed and used to screen reagents. A subsequent
>> drug screen led to the discovery of the novel anti-HIV activity of
>> cyclonucleoside compounds. Further studies revealed that the
>> mechanism of action of these compounds on HIV was likely due to the
>> inhibition of deoxynucleotide metabolic pathways, causing
>> deoxynucleotide pool imbalances leading to lethal mutagenesis in both
>> HIV DNA and RNA synthesis.
>>
>> ###
|
|
|